U.S. Asthma Therapeutics Market New Product Classes Offer Significant Growth Opportunities “The...
6
U.S. Asthma Therapeutics Market New Product Classes Offer Significant Growth Opportunities “The emergence of leukotriene modifiers and combination therapies show promise in a highly competitive market. Convenience is the primary advantage of combination therapies, as these pills combine two or more asthma drugs into one dosage, making treatment more efficient.” Pharmaceuticals Analyst Team Frost & Sullivan
-
Upload
bertina-morgan -
Category
Documents
-
view
214 -
download
0
description
Coverage: The United States Proven methodology using extensive primary and secondary data as well as research Focused information and strategies that cover business and technology issues Credible data and analyses that highlight industry dynamics Precise strategies to help you create winning business plans What We Offer
Transcript of U.S. Asthma Therapeutics Market New Product Classes Offer Significant Growth Opportunities “The...
U.S. Asthma Therapeutics Market
New Product Classes Offer Significant Growth Opportunities
“The emergence of leukotriene modifiers and combination therapies show promise in a highly competitive market. Convenience is the primary
advantage of combination therapies, as these pills combine two or more asthma drugs into one dosage, making treatment more efficient.”
Pharmaceuticals Analyst Team
Frost & Sullivan
• Detailed insights into recent developments and trends
• Drivers, restraints, challenges, and strategic recommendations
• Analytical insights into ‘hot topics’ and emerging applications in the asthma therapeutics market.
• Market-sizing and competitive analysis
• Market forecasts and opportunity analyses
• Quarterly assessments
• End-user analysis
Key Features
• Coverage: The United States
• Proven methodology using extensive primary and secondary data as well as research
• Focused information and strategies that cover business and technology issues
• Credible data and analyses that highlight industry dynamics
• Precise strategies to help you create winning business plans
What We Offer
Current Market Participants• Find out how you compare with the competition• Assess current and future drivers as well as restraints• Determine and exploit new market share opportunities
New Entrants • Analyze the associated challenges• Calculate timescales for strategy implementation• Position yourself to capitalize on the unmet needs of the market
Investment Community• Analyze long-term strategies of companies • Determine which participants will outperform the competition• Assess the attractiveness of investing in the market
Who Will Benefit?
Alpharma, Inc./U.S. Pharmaceutical DivisionAstraZenecaAstraZeneca LPAventis Pharmaceuticals, Inc.Bausch & Lomb Pharmaceuticals, Inc.Boehringer Ingelheim GmbhCopley Pharmaceuticals, Inc.Dey, Inc.Dura Pharmaceuticals, Inc.
Key Market Participants
GlaxoSmithKlineMedeva Pharmaceuticals, Inc.Novartis Pharmaceuticals Corp.Pfizer, Inc.Purdue Pharma LPSanofi-Synthelabo, Inc.Schering-Plough Corp.Teva Pharmaceutials USA
• Call toll free 877 GO FROST (877.463.7876)
• Fax toll free 888.690.3329
• E-mail [email protected]
• Visit www.frost.com
For More Information
